PHLDA2 and hydatidiform mole: However, only a few studies have reported on the relationship between PHLDA2 and human cancers, including the loss of PHLDA2 expression in complete hydatidiform moles, Wilms’ tumors, brain cancer and osteosarcoma [21, 36–38].